137 related articles for article (PubMed ID: 17923754)
21. Aneuploidy of chromosome 7 can be detected in invasive lung cancer and associated premalignant lesions of the lung by fluorescence in situ hybridisation.
Zojer N; Dekan G; Ackermann J; Fiegl M; Kaufmann H; Drach J; Huber H
Lung Cancer; 2000 Jun; 28(3):225-35. PubMed ID: 10812191
[TBL] [Abstract][Full Text] [Related]
22. The use of genetic markers to identify lung cancer in fine needle aspiration samples.
Gill RK; Vazquez MF; Kramer A; Hames M; Zhang L; Heselmeyer-Haddad K; Ried T; Shilo K; Henschke C; Yankelevitz D; Jen J
Clin Cancer Res; 2008 Nov; 14(22):7481-7. PubMed ID: 19010865
[TBL] [Abstract][Full Text] [Related]
23. Unproductive Effects of ALK Gene Amplification and Copy Number Gain in Non-Small-Cell Lung Cancer. ALK Gene Amplification and Copy Gain in NSCLC.
Zito Marino F; Botti G; Aquino G; Ferrero S; Gaudioso G; Palleschi A; Rocco D; Salvi R; Micheli MC; Micheli P; Morabito A; Rocco G; Giordano A; De Cecio R; Franco R
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664698
[No Abstract] [Full Text] [Related]
24. Genomic profiles in stage I primary non small cell lung cancer using comparative genomic hybridization analysis of cDNA microarrays.
Jiang F; Yin Z; Caraway NP; Li R; Katz RL
Neoplasia; 2004; 6(5):623-35. PubMed ID: 15548372
[TBL] [Abstract][Full Text] [Related]
25. Assessment of the clinical relevance of 17q25.3 copy number and three-dimensional telomere organization in non-small lung cancer patients.
Sunpaweravong P; Thu KL; Lam WL; Mai S
J Cancer Res Clin Oncol; 2016 Apr; 142(4):749-56. PubMed ID: 26621152
[TBL] [Abstract][Full Text] [Related]
26. Genomic alterations in lung adenocarcinomas detected by multicolor fluorescence in situ hybridization and comparative genomic hybridization.
Shen H; Zhu Y; Wu YJ; Qiu HR; Shu YQ
Cancer Genet Cytogenet; 2008 Mar; 181(2):100-7. PubMed ID: 18295661
[TBL] [Abstract][Full Text] [Related]
27. Chromosome 5p aberrations are early events in lung cancer: implication of glial cell line-derived neurotrophic factor in disease progression.
Garnis C; Davies JJ; Buys TP; Tsao MS; MacAulay C; Lam S; Lam WL
Oncogene; 2005 Jul; 24(30):4806-12. PubMed ID: 15870700
[TBL] [Abstract][Full Text] [Related]
28. Genetic screening and molecular characterization of MET alterations in non-small cell lung cancer.
Saigi M; McLeer-Florin A; Pros E; Nadal E; Brambilla E; Sanchez-Cespedes M
Clin Transl Oncol; 2018 Jul; 20(7):881-888. PubMed ID: 29139039
[TBL] [Abstract][Full Text] [Related]
29. Genetic changes in clinically organ-confined prostate cancer by comparative genomic hybridization.
Fu W; Bubendorf L; Willi N; Moch H; Mihatsch MJ; Sauter G; Gasser TC
Urology; 2000 Nov; 56(5):880-5. PubMed ID: 11068328
[TBL] [Abstract][Full Text] [Related]
30. Investigation of c-myc and p53 gene alterations in the tumor and surgical borderline tissues of NSCLC and effects on clinicopathologic behavior: by the FISH technique.
Yakut T; Egeli U; Gebitekin C
Lung; 2003; 181(5):245-58. PubMed ID: 14705768
[TBL] [Abstract][Full Text] [Related]
31. Comparison between fluorescence in situ hybridization and classical cytogenetics in human tumors.
Virmani AK; Tonk VS; Gazdar AF
Anticancer Res; 1998; 18(3A):1351-6. PubMed ID: 9673339
[TBL] [Abstract][Full Text] [Related]
32. Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer.
Lai GGY; Lim TH; Lim J; Liew PJR; Kwang XL; Nahar R; Aung ZW; Takano A; Lee YY; Lau DPX; Tan GS; Tan SH; Tan WL; Ang MK; Toh CK; Tan BS; Devanand A; Too CW; Gogna A; Ong BH; Koh TPT; Kanesvaran R; Ng QS; Jain A; Rajasekaran T; Yuan J; Lim TKH; Lim AST; Hillmer AM; Lim WT; Iyer NG; Tam WL; Zhai W; Tan EH; Tan DSW
J Clin Oncol; 2019 Apr; 37(11):876-884. PubMed ID: 30676858
[TBL] [Abstract][Full Text] [Related]
33. Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy.
Hirsch FR; Herbst RS; Olsen C; Chansky K; Crowley J; Kelly K; Franklin WA; Bunn PA; Varella-Garcia M; Gandara DR
J Clin Oncol; 2008 Jul; 26(20):3351-7. PubMed ID: 18612151
[TBL] [Abstract][Full Text] [Related]
34. HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridization.
Tan D; Deeb G; Wang J; Slocum HK; Winston J; Wiseman S; Beck A; Sait S; Anderson T; Nwogu C; Ramnath N; Loewen G
Diagn Mol Pathol; 2003 Dec; 12(4):201-11. PubMed ID: 14639106
[TBL] [Abstract][Full Text] [Related]
35. Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization.
Luk C; Tsao MS; Bayani J; Shepherd F; Squire JA
Cancer Genet Cytogenet; 2001 Mar; 125(2):87-99. PubMed ID: 11369051
[TBL] [Abstract][Full Text] [Related]
36. A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC).
Azad AK; Qiu X; Boyd K; Kuang Q; Emami M; Perera N; Palepu P; Patel D; Chen Z; Cheng D; Feld R; Leighl NB; Shepherd FA; Tsao MS; Xu W; Liu G; Cuffe S
Lung Cancer; 2014 Jun; 84(3):289-94. PubMed ID: 24679952
[TBL] [Abstract][Full Text] [Related]
37. 2q-, a non-random chromosomal abnormality in human non-small-cell lung cancer.
Lu YJ; Dong XY; Guo SP; Zhang RG; Ke Y; Zhang LZ; Xu LH; Cheng SJ
Carcinogenesis; 1996 Aug; 17(8):1589-93. PubMed ID: 8761414
[TBL] [Abstract][Full Text] [Related]
38. Loss of 4q21.23-22.1 is a prognostic marker for disease free and overall survival in non-small cell lung cancer.
Uzunoglu FG; Dethlefsen E; Hanssen A; Wrage M; Deutsch L; Harms-Effenberger K; Vashist YK; Reeh M; Sauter G; Simon R; Bockhorn M; Pantel K; Izbicki JR; Wikman H
PLoS One; 2014; 9(12):e113315. PubMed ID: 25501003
[TBL] [Abstract][Full Text] [Related]
39. Complex duplications at 6p22.1, 6p11.2, 5q13, 5p15.1 and 5p13 revealed by fluorescent in situ hybridisation.
Rhodes DA; Volz A; Jones T; Ziegler A; Trowsdale J
DNA Seq; 1997; 8(3):161-5. PubMed ID: 10668962
[TBL] [Abstract][Full Text] [Related]
40. [EGFR and HER2 gene expression status and their correlation in non-small cell lung cancer].
Zeng X; Wu SF; Zhou WX; Li DJ; Gao J; Liang ZY; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2006 Jul; 35(7):398-402. PubMed ID: 17069674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
